CA Patent

CA2344919A1 — Active enantiomer of rar.gamma.-specific agonist

Assigned to Bristol Myers Squibb Co · Expires 2000-03-30 · 26y expired

What this patent protects

Disclosed is the (R)-enantiomer of formula (I), which has unexpectedly been found to possess all of the biological activity of the racemic compound disclosed in the prior art as an RAR.gamma.-specific agonist.

USPTO Abstract

Disclosed is the (R)-enantiomer of formula (I), which has unexpectedly been found to possess all of the biological activity of the racemic compound disclosed in the prior art as an RAR.gamma.-specific agonist.

Drugs covered by this patent

Patent Metadata

Patent number
CA2344919A1
Jurisdiction
CA
Classification
—
Expires
2000-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.